Treatment
Human Umbilical Cord Mesenchymal Stem Cells clinical trials
We’re tracking 27 recruiting studies that include Human Umbilical Cord Mesenchymal Stem Cells, each written for real people, not researchers, below.
Recruiting studies
- NCT04357600Enrolling by invitationPhase 1/Phase 2
Stem cell treatment for hepatitis B–related cirrhosis
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
Jakarta, DKI JakartaAges 18–65 - NCT04356287RecruitingPhase 1/Phase 2
Cord cell treatment for severe systemic sclerosis symptoms
This early-phase study tests whether umbilical cord-derived “cord blood–type” cells can reduce or improve severe systemic sclerosis (a type of hardening/scarring disease of connective tissue). It may help people whose current standard treatments haven’t worked or caused side effects.
Montreal, QuebecAges 18 years+ - NCT04104412RecruitingPhase 1
Stem cell injection study for long-lasting disc back pain
This Phase 1 study tests the safety and early effectiveness of an umbilical cord stem cell injection for people with persistent lumbar (lower back) disc-related pain that has not improved with standard care. If you qualify, it may offer a new treatment option, while researchers closely monitor side effects and pain changes.
Beijing, Beijing MunicipalityAges 18 years+
Common questions
- Are there clinical trials studying Human Umbilical Cord Mesenchymal Stem Cells?
- Yes. Clin2 currently lists 27 recruiting studies that include Human Umbilical Cord Mesenchymal Stem Cells, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Human Umbilical Cord Mesenchymal Stem Cells trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Human Umbilical Cord Mesenchymal Stem Cells an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Human Umbilical Cord Mesenchymal Stem Cells or a specific trial is right for you.
Related treatments
- Umbilical Cord Mesenchymal Stem Cell
- Umbilical Cord Blood-Derived Stem Cells and Exosomes
- Mesenchymal Stem Cells
- Human Dopaminergic Progenitor Cells
- Mesenchymal Stromal Cells
- Mesenchymal Stem Cell
- Umbilical Cord Blood
- Base-edited hematopoietic stem and progenitor cells
- Β-globin Restored Autologous Hematopoietic Stem Cells
- CAR-T cells
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.